Suivez-nous sur Linked In
Suivez-nous sur Youtube

Transdisciplinary Immunology Journal Club #TIJC

Open to all immunology enthusiasts !
A club that brings together autoimmunity and cancer, 
two worlds linked by one bridge.

Welcome to the Transdisciplinary Immunology Journal Club (TIJC) — your global hub for cutting-edge immunology, cross-disciplinary insights, and career development. TIJC unites physicians, researchers, and students worldwide to explore breakthroughs in immunology, oncology, autoimmunity, and translational medicine.

Featured Sessions

TITLESPEAKERDATE (CET) / REPLAY
TBCManon Lesturgie TalarekSeptember ?, 2026 – 16h
TBCJoline IngelsJune 18, 2026 – 16h
TBCFrancesca Lucibello May 6, 2026 – 15h
Location-Specific T-cell Inhibitory Molecules (LoSTIMs) for targeted immunosuppression James Torchia April 23, 2026 – 16h
Emerging Roles of Endogenous Retroelements in Immunity
From tissue senescence to regulation of adaptive immune responses , targeting retroelements as a strategy to mitigate immune-mediated diseases
Nader Yatim March 26, 2026 – 15h
Innate immune dysfunction in VEXAS syndrome Paul BreillatFeb 12, 2026 – 16h
Aging, Immunosenescence & Immunotherapies Marie Naigeonn/a
Accelerating Cancer Immunotherapy Research (ACIR) Ute Burkhardt & Ed FritschWatch Replay
CD19 CAR T Cell Therapy in Multidrug Resistant Ulcerative Colitis (NEJM 2025) Antoine MeyerWatch Replay
High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy Lucas BlanchardWatch Replay
NK Cells Restrict CD8+ T Cells in Submandibular Gland via PD-1–PD-L1 + irAE Colitis David ZemmourWatch Replay
Organoid Co-Culture Model for Systemic Anti-Tumor Immunity in Lung Cancer Negaar GoudarziPostponed
Anti-PD-1 Amplifies Co-Stimulation in Melanoma-Infiltrating Th1-like Foxp3+ Tregs Mikhaël AttiasWatch Replay
HLA Class I Peptide Polymorphisms and Antibody Specificity Cédric UsureauWatch Replay
Evolution of Myeloid-Mediated Immunotherapy Resistance in Prostate CancerSimon CoibaWatch Replay
Neoantigen Vaccines in Precision Oncology Adrien MourenWatch Replay
Rapid Establishment of CD8+ T Cell Dysfunction upon Tumor Antigen EncounterMatthieu Roulleau DugageWatch Replay
Disrupting Antitumor Immune Axis by Targeting CD206+ Macrophages Marie RobertWatch Replay
Revitalizing Exhausted CD8+ T Cells with Fc–IL-4 François-Xavier DanlosWatch Replay
JAK Inhibitors and Cancer: Friend or Foe?Samuel BitounWatch Replay

Watch all Replays below
Follow us on LinkedIn to never miss a session !


12 Feb 2026

Innate immune dysfunction in VEXAS: mechanisms of inflammation and infection risk #tijc

Accelerating Cancer Immunotherapy Research (ACIR) – journal club #tijc

CD19 CAR TCell Therapy in MultidrugResistant Ulcerative Colitis (NEJM 2025) – Journal Club #tijc

HEVs : specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy #tijc

NK cells regulate CD8+ T cells via PD 1PD L1 & Immunotherapy Induced Colitis – Journal Club #tijc

CD8+ T Cell Dysfunction Begins Hours After Tumor Antigen Exposure – Journal Club #tijc

Evolution of myeloid mediated immunotherapy resistance in prostate cancer – Journal Club #tijc

Neoantigen vaccines a new era of precision medicine in oncology – Journal Club #tijc

Tregs & Anti PD 1 #TIJC – Journal Club #tijc

HLA Class I Peptide Polymorphisms and Antibody Specificity – Journal Club #tijc

Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis #tijc

The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer – Journal Club #tijc

JAK Inhibitors and Cancer: Friend or Foe? Dr Samuel Bitoun – Journal Club #tijc